Ticker Details
Taysha Gene Therapies, Inc.
IPO Date:	September 24, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.95B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.28 | 4.68%
Avg Daily Range (30 D):	$0.19 | 3.17%
Avg Daily Range (90 D):	$0.22 | 3.60%

Institutional Daily Volume
Avg Daily Volume:	1.73M
Avg Daily Volume (30 D):	2.32M
Avg Daily Volume (90 D):	2.34M

Trade Size
Avg Trade Size (Sh.):	191
Avg Trade Size (Sh.) (30 D):	113
Avg Trade Size (Sh.) (90 D):	110

Institutional Trades
Total Institutional Trades:	791
Avg Institutional Trade:	$2.09M
Avg Institutional Trade (30 D):	$2.99M
Avg Institutional Trade (90 D):	$2.83M
Avg Institutional Trade Volume:	.52M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.51M
Avg Closing Trade (30 D):	$2.05M
Avg Closing Trade (90 D):	$3M
Avg Closing Volume:	564.23K

News

Jun 25, 2026 @ 2:33 AM Taysha Gene Therapies Announces Pricing of Public ... Source: Na

Apr 29, 2026 @ 12:00 PM Taysha Gene Therapies to Release First Quarter 202... Source: Not Specified

Apr 3, 2026 @ 12:00 PM Taysha Gene Therapies Announces Inducement Grant U... Source: Na

Mar 19, 2026 @ 12:00 PM Taysha Gene Therapies Reports Full-Year 2025 Finan... Source: Not Specified

Feb 6, 2026 @ 1:00 PM Taysha Gene Therapies Announces Inducement Grant U... Source: Na

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.41	$-.13	$-.12
Diluted EPS	$-.41	$-.13	$-.12
Revenue	$5.49M	$M	$M
Gross Profit
Net Income / Loss	$-149.63M	$-46.64M	$-42.41M
Operating Income / Loss	$-153.16M	$-47.35M	$-43.49M
Cost of Revenue
Net Cash Flow	$140.21M	$176.23M	$-43.19M
PE Ratio